24-HOUR MH HOTLINE
Outside NA: 001-209-417-3722
FOR EMERGENCIES ONLY
MHAUS President Henry Rosenberg, MD talks with Edward Nemergut, MD of OpenAnesthesia.org about malignant hyperthermia during an interview that was recorded in January. Click this link to listen.
About OpenAnesthesia: OpenAnesthesia (OA), sponsored by the International Anesthesia Research Society, is an online multimodal toolkit specifically designed to advance graduate medical education in anesthesia. Resident physicians can discover and appreciate the primary medical literature by reading, creating and editing wiki pages on OA, and Program Directors can use OA to document core competency activities for Accreditation Council for Graduate Medical Education-mandated learning portfolios.
About Malignant Hyperthermia: MH is an autosomal dominant genetic disorder found in an estimated 1 out of 2,000 people. Once triggered, the rapid progressive series of chain events include a body temperature of up to 107 degrees, muscle rigidity, system-wide organ failure, and, if untreated, eventual death. MH is often experienced in individuals undergoing, what was expected to be, routine surgery. The incidence of MH is low, but, if untreated, the mortality rate is high. Introduction of a treatment drug and advances in the understanding of MH have saved many lives since the syndrome was first described in the 1960s.
About the Malignant Hyperthermia Association of the United States (MHAUS): Founded in 1981 MHAUS is the only organization in North America dedicated to promoting optimum care and scientific understanding of MH and related disorders by encouraging healthcare professionals and patients and families to prepare for MH through education and testing and through the 24-hour MH Hotline that provides healthcare professionals with access to experts that specialize in MH crisis treatment.